BCR and posterior cortical atrophy: Although BCR is likely to continue to occur with further follow-up, our results appear promising compared with other HDR-BT studies in unfavorable-risk PCa, where the BCRFS rates varied between 59 and 94% with or without hormonal therapy (with more than 5‐year median follow-up) [2, 15, 16].